Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-22

FDA Approved: OLANZAPINE — Supplemental Application (Modavar Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Modavar Pharmaceuticals LLC's supplemental application to market a generic olanzapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)